| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
07-24-2017, 01:50 PM
|
#1 | ||
|
|||
|
News Gatherer
Community Support Team
|
Parkinson's News Today Prana and Takeda Will Investigate PBT434 as Treatment for Gastrointestinal Damage in Parkinson's Parkinson's News Today Prana Biotechnology and Takeda Pharmaceuticals International are teaming up to investigate whether Prana's PBT434 can improve gastrointestinal damage associated with Parkinson's disease. PBT434 showed promise as a treatment for neuronal loss and ... More... |
||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| review of Prana Biotechnology mentions MND treatment | ALS News & Research | |||
| Damage From no treatment | Myasthenia Gravis | |||
| Parkinson's Drug PBT434 in the US | Parkinson's Disease | |||
Prana and Takeda Will Investigate PBT434 as Treatment for Gastrointestinal Damage in
Linear Mode
